Hamlet building the case for 'bulldozer' cancer drug Nov. 6, 2019 By Cormac Sheridan No Comments DUBLIN Hamlet Pharma AB is about to embark on the next phase in the clinical development of its novel cancer therapy, a constituent of human breast milk that has a selective effect on disrupting the membranes of cancer cells. Read More